![]() | ![]() |
Formats:
|
||||||||||||||
Cell Biology Cyclin A–Cdk1 regulates the origin firing program in mammalian cells aDepartment of Cell Biology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan; bLaboratory of Molecular and Cellular Biology, Graduate School of Bioresources, Mie University, 1577 Kurimamachiya-cho, Tsu, Mie 514-8507, Japan; cCellular Physiology Laboratory, RIKEN Discovery Research Institute, and Solution Oriented Research for Science and Technology, Science and Technology Corporation, Wako, Saitama 351-0198, Japan; and dFaculty of Science, Gakushuin University, Toshima, Tokyo 171-8588, Japan 1To whom correspondence should be addressed. E-mail: mkt-naka/at/med.nagoya-cu.ac.jp Edited by Tak Wah Mak, University of Toronto, Toronto, Canada, and approved January 12, 2009 Author contributions: M.N. designed research; Y.K., A.S., K.S., K.O., D.H.Z., M.S., and H.N. performed research; T.M. and F.H. contributed new reagents/analytic tools; Y.K., K.S., and M.N. analyzed data; and Y.K. and M.N. wrote the paper. Received September 18, 2008. This article has been cited by other articles in PMC.Abstract Somatic mammalian cells possess well-established S-phase programs with specific regions of the genome replicated at precise times. The ATR–Chk1 pathway plays a central role in these programs, but the mechanism for how Chk1 regulates origin firing remains unknown. We demonstrate here the essential role of cyclin A2–Cdk1 in the regulation of late origin firing. Activity of cyclin A2–Cdk1 was hardly detected at the onset of S phase, but it was obvious at middle to late S phase under unperturbed condition. Chk1 depletion resulted in increased expression of Cdc25A, subsequent hyperactivation of cyclin A2–Cdk1, and abnormal replication at early S phase. Hence, the ectopic expression of cyclin A2–Cdk1AF (constitutively active mutant) fusion constructs resulted in abnormal origin firing, causing the premature appearance of DNA replication at late origins at early S phase. Intriguingly, inactivation of Cdk1 in temperature-sensitive Cdk1 mutant cell lines (FT210) resulted in a prolonged S phase and inefficient activation of late origin firing even at late S phase. Our results thus suggest that cyclin A2–Cdk1 is a key regulator of S-phase programs. Keywords: Chk1, DNA replication, molecular combing, ATR protein, checkpoint Duplication of the eukaryotic genome is regulated by multiple elements including initiation of DNA replication, rate of fork progression, stability of replication forks, and the origin firing program (1). Replication origins are fired in small groups that are activated together within individual replication factories and thus can be visualized as foci (2). Replication origins in a single replication factory are actually comprised of several candidate origins, most of which are not normally used through the mechanism by which firing of 1 origin inhibits activation of any other Mcm2–7 complexes within that factory (3). Thus, S-phase programs appear to be regulated by 2 distinct levels of origin firing; one is the sequential activation of replicon clusters characterized as visible replication foci, and the other is the selection of 1 Mcm2–7 complex around the ORC within a single replication factory. The DNA replication checkpoint system was reported to be involved in the origin firing program in vertebrate cells (4). In analysis using Xenopus egg extract, ATR/Chk1 was shown to regulate the sequential activation of early and late replication origins (5). Chk1 also regulates the density of active replication origins during S phase of avian cells (6). Therefore, ATR/Chk1 may be involved in the regulation of sequential activation of replicon clusters and selection of origins within a single replication factory. Chk1 has been shown to regulate the physiological turnover of Cdc25A and its phosphatase activity, which in turn regulates several cyclin–Cdk activities (7) that are prerequisite for origin firing throughout S phase. In budding yeast, Clb5-dependent Cdk activity is indispensable for activation of late replication origins (8), suggesting the existence of a specific transfactors for late origin activation in other eukaryotes. In fission yeast, however, clear late origins have not been characterized (9) and replication origins fire stochastically (10, 11). As for mammals, although almost half of origins are activated equally throughout S-phase progression (12), stable subunits of chromosomes equivalent to replication foci maintain their replication timing from S phase to S phase (13). In this article, we demonstrate that Chk1 depletion resulted in an aberrant origin firing and a hyperactivation of cyclin A2–Cdk1 at early S phase. Ectopic expression of cyclin A2–Cdk1AF induced late origin firing at early S phase, and a loss of Cdk1 activity compromised activation of late origins at late S phase. Our results thus suggested that cyclin A2–Cdk1 might function as a transregulator of late origin firing in mammals. Results Chk1 Depletion Results in an Aberrant Origin Firing and a Hyperactivation of Cyclin A2–Cdk1 at Early S Phase. Chk1lox/− mouse embryonic fibroblasts (MEFs) were infected with adenoviruses expressing either LacZ or Cre and synchronized into G0 phase by serum starvation (14). Chk1lox/− and Chk1del/− MEFs were then stimulated by 15% serum and double-labeled with iododeoxyuridine (IdU) and chlorodeoxyuridine (CIdU) at the indicated times, and their spatiotemporal patterns of replication sites were examined. The mammalian S phase is structured so that the sequential activation of replicon clusters occurs at spatially adjacent sites (15). This spatial relationship is maintained in Chk1lox/− MEFs (Fig. 1
Double-labeling protocol also defines 5 classes of replication structure as described (6). Chk1 depletion resulted in a significant reduction in a proportion of consecutively elongating forks (class 1) and an increase in number of new firing initiation during the first (class 2) and second (class 4) labeling period (Fig. 1 We next examined whether Chk1 regulates global sites of DNA synthesis by quantitative ChIP using FACS-based cell sorting (16). To avoid unexpected effects from gross changes in cell cycle profile on this analysis, we analyzed Chk1del/− MEFs 28 h after adenoviral infection, the time at which Chk1 was completely depleted, but the cell cycle profile was almost the same as that of Chk1lox/− cells (Fig. 1 Chk1 is phosphorylated during unperturbed S phase (18, 19), which regulates the activity and stability of Cdc25 phosphatases, leading to the inactivation of Cdks through increased phosphorylation of their Y15 residues (20). Thus, we speculated that Chk1 regulates origin firing program through affecting certain cyclin–Cdks activities. The band corresponding to Chk1 was shifted upward at 15 h and thereafter. This band shift was reversed by phosphatase treatment, indicating that the modification was caused by phosphorylation. Chk1 phosphorylation was also confirmed by using phospho-specific antibodies to Chk1 at Ser-317 and Ser-345 (Fig. 1 Cyclin A2–Cdk1 activity was first detected at 15 h (middle S phase) and increases thereafter. Cyclin A2–Cdk2 was detected at 6 h (early S phase) and reached maximum at 18 h (Fig. 1 Aberrant Origin Firing in Cells Expressing Cyclin A2–Cdk1AF Fusion Protein. To examine the role of each cyclin–Cdk complex in the origin firing program, we generated a cyclin A2–Cdk1 fusion construct. Because cyclin–Cdk activities are regulated mainly by the phosphorylation of Y15, we generated a constitutively active mutant (CdkAF) in which residues at inhibitory phosphorylation sites were replaced with alanine and phenylalanine and therefore the mutant was not affected by the Chk1–Cdc25 pathway. Recombinant cyclin A2–Cdk2AF, cyclin A2–Cdk1AF, and cyclin B1–Cdk1AF complexes and the fusion proteins were examined for their enzymatic kinetics by using histone H1 (HH1) and lamin B as substrates. Dose-dependent increases in activities of both cyclin–Cdks complex and their fusion proteins were observed (Fig. 2
Expression of cyclin B1–Cdk1AF, but not cyclin A2–Cdk2AF or cyclin A2–Cdk1AF, induced γH2AX foci in HeLa cells (Fig. 2 Expression of cyclin A2–Cdk1AF and cyclin A2–Cdk2AF fusion protein at the endogenous level did not appear to affect the gross progression of S phase (Fig. 3
ChIP analysis revealed that considerable enrichment of early- and late-replicating DNA was specifically observed in the early and late S-phase fractions of control LacZ cells, respectively (Fig. 3 Cdk1 Is Required for Proper Timing of Origin Firing. FT210 cells possess a temperature-sensitive Cdk1 gene product (22). FACS analysis revealed a 2-h-longer S phase in FT210 cells compared with the parental FM3A cells (Fig. 4
ChIP analysis revealed that replication patterns of early S-phase fractions in both cells were very similar, whereas replication of late origins in late S-phase fraction from FT210 cells was specifically impaired (Fig. 5
Finally, we attempted to determine the molecular basis by which cyclin A2–Cdk1 regulates origin firing program. In Xenopus and yeast systems, it was reported that cyclins, Cdk1 specifically, interact with the origin recognition complexes (ORCs) (23, 24). To examine whether the specific interaction of Cdk1 to ORCs is conserved among mammals, we performed ChIP analysis with α-Cdk1 and α-Cdk2 antibodies. Both Cdk1 and Cdk2 were detected at genes replicating early, whereas Cdk1 was specifically detected at genes replicating late (Fig. 5 Discussion Conditional Chk1 knockout MEFs revealed that Chk1 plays an important role in the regulation of origin firing at 2 distinct levels in mammals, namely activation of origins within a single replication factory and activation of replicon clusters (Fig. 1 Neither cyclin A2–Cdk1 nor cyclin A2–Cdk2 appeared to be involved in the stabilization of replication forks during S phase when replication structures were assessed by dynamic molecular combing technology (Fig. 3 Cdk activities have both positive and negative roles during S phase, namely to initiate DNA synthesis and prevent rereplication. A quantitative model has proposed for explain the biphasic effects of Cdks (28). In addition to a quantitative model, the accessibility of Cdk to substrates could play a role in the regulation of the S-phase program. Studies in Xenopus and yeast systems suggested that Cdk1 specifically interacts with ORC and phosphorylates the components more efficiently than Cdk2 although this interaction is proposed to be involved in prevention of rereplication (23, 24). We found that Cdk1 could bind to both early and late origins but Cdk2 failed to bind to late origins (Fig. 5 In conclusion, the present results indicate that ATR/Chk1–cyclin A2–Cdk1 controls the activation of late replication origins and the density of active origins in mammals. Similar regulation was reported in a budding yeast system in which Clb5–Cdk1 was required for late origin firing (8). Taken together, these results suggest the existence of conserved mechanisms for the temporal program of origin activation among a number of eukaryotes. Materials and Methods Antibodies. Antibodies used in this study were as follows: α-CDK2 (sc-748; Santa Cruz), α-Cyclin A2 (sc-751; Santa Cruz), α-Cdc2 (sc-54; Santa Cruz), α-Cyclin B1 (sc-245; Santa Cruz), rat α-BrdU (ab6326; Abcam), mouse α-BrdU (347580; BD), α-γH2AX (05-636; Upstate), α-rabbit IgG HRP (NA934; GE Healthcare), α-mouse IgG HRP (NA931; GE Healthcare), Alexa Fluor 555-conjugated goat α-mouse IgG (A-21422; Invitrogen), and Alexa Fluor 488-conjugated rabbit α-rat IgG (A-21210; Invitrogen). Cell Culture and Double Labeling with IdU and CIdU. HeLa cells, Chk1lox/− MEFs, Chk1del/− MEFs, FM3A, and FT210 cells were cultured as described (14, 29). For analyses of origin firing programs, cells were incubated with 100 μM IdU for 15 min, then 100 μM CIdU for 15 min, fixed with 4% paraformaldehyde, and permabilized. Cellular DNA was denatured in 1.5 M HCl and stained as reported (6). The spatiotemporal patterns of replication were analyzed by counting at least 300 cells by 2 individuals under blinded conditions. Dynamic Molecular Combing and Immunofluorescent Detection. Genomic DNA was prepared and combed onto the silanated cover slips as described (30) with modifications as detailed (31). A total of 2 × 106 cells were pulse-labeled for 20 min with 100 μM IdU, washed with PBS twice, and pulse-labeled for 20 min with 100 μM CIdU. For preparation of genomic DNA, to remove the mitochondrial genome the nuclei were extracted with buffer A [250 mM sucrose, 20 mM Hepes (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA (pH 8.0), 1 mM EGTA (pH 6.8), 1 mM DTT, 0.1 mM PMSF] before resuspension into low-melting point agarose. Combed DNA molecules were heat-denatured in 50% formamide, 2 × SSC at 72 °C for 12 min. For immunodetection of labeled DNA, denatured DNA molecules were incubated with mouse α-BrdU mAb (1:5) and rat α-BrdU mAb (1:25) for 1 h at 37°C. After washing with PBS and 0.05% Tween 20 for 5 min 3 times, DNA molecules were incubated with Alexa Fluor 555-conjugated goat α-mouse IgG (1:500) and Alexa Fluor 488-conjugated rabbit α-rat IgG (1:500) for 30 min at 37°C. All antibodies were diluted in blocking solution [1% (wt/vol) blocking reagent in PBS, 0.05% Tween 20]. After washing with PBS and 0.05% Tween 20 for 5 min 3 times, coverslips were mounted in VECTASHIELD (Vector Laboratories). To estimate the extension of DNA molecules, coverslips were prepared with λ-DNA, and then the DNA molecules were stained with 6.7 mM YOYO-1 at 25°C for 1 h. YOYO-1-stained DNA molecules measured 21 ± 0.9 μm. As the virus genome is 48.5 kbp, the extension of DNA molecules is 2.32 ± 0.11 kbp/μm. DNA fibers were examined with a Zeiss Axioplan 2 MOT with a 63X Plan-APOCHROMAT (NA 1.4) objective lens, equipped with MicroMAX CCD camera (Princeton Instruments). Fluorescent signals were measured by using MetaMorph version 6.1 software (Universal Imaging). Construction of Cyclin A2–Cdk1, Cyclin A2–Cdk2, and Cyclin B1–Cdk1 Fusion Vectors. For subcloning of full-length mouse Cdk1 and Cdk1AF, either cDNAs from mouse MEFs or pcDNA3.1Cdk1AF were used as a template. The PCR products were digested with EcoRI and NotI and subcloned into pcDNA3.1Myc/HisA vector (Invitrogen). For subcloning of full-length mouse Cdk2 and Cdk2AF, either cDNAs from mouse MEFs or pcDNA3.1Cdk2AF were used as a template. For preparation of cyclin A2–Cdk1, cyclin A2–Cdk2, and cyclin B1–Cdk1 fusion constructs, sets of primers and mouse cDNA derived from MEFs as a template were used. The PCR products were digested with BamHI and EcoRI and subcloned into pcDNA3.1Cdk1Myc/HisA or pcDNA3.1Cdk2Myc/HisA vectors. The primer sets used are listed in Table S1. Purification of Recombinant Cyclin–Cdk Fusion Proteins. pcDNA3.1cyclin A2–Cdk1, pcDNA3.1cyclin A2–Cdk2, pcDNA3.1cyclin B1–Cdk1, and their AF mutants were digested with BamHI and PmeI. The fragments were subcloned into pVL1392 vector and transfected into Sf9 cells. Sf9 cells infected with baculoviruses expressing cyclin–Cdk fusion proteins or coinfected with the individual cyclins and Cdks were lysed with immunoprecipitation kinase buffer (7) containing a mixture of protease inhibitors. The fusion proteins and cyclin–Cdk complexes were purified by ProBond Resin (Invitrogen) and used for the in vitro kinase assay. Preparation of Adenoviruses Expressing Cyclin–Cdk Fusion Proteins. The BamHI–PmeI fragments of cyclin–Cdk fusion constructs were subcloned into pENTER vector (Invitrogen) predigested with BamHI and EcoRV. pENTERcyclin–Cdks and pENTERcyclin–CdkAFs were then subcloned into pAdCMV vectors according to the manufacturer's instructions (Invitrogen). pAdcyclin–Cdks and pAdcyclin–CdkAFs were transfected into 293A cells (Invitrogen). ChIP Assay. Asynchronized Chk1lox/− MEFs, Chk1del/− MEFs, HeLa cells infected with adenoviruses expressing cyclin A2–Cdk1AF or cyclin A2–Cdk2AF, and mouse FM3A or FT210 cells were labeled with 25 μM BrdU before cell sorting. Cells were then sorted into early and late S-phase fractions by using a cell sorter (BD). At least 60,000 cells were collected during each phase and used for the chromatin preparation. Nascent DNA was enriched by immunoprecipitation using α-BrdU antibodies as reported (16) and subjected to quantitative PCR with the ABI PRISM7000 system using Power SYBR Green PCR Master Mix (Applied Biosystems). Primers used for PCR are listed in Table S1. As a control, mtDNA in BrdU-containing DNA was also amplified, and the results were presented as a percentage of mtDNA. For Cdk1 and Cdk2 bindings to origins, FM3A cells were cultured at 33 °C, and ChIP analysis was performed with α-Cdk1 and α-Cdk2 antibodies as described (14). The results were presented as a percentage of input. Supporting Information
Acknowledgments. We thank Dr. C. Namikawa-Yamada, Mr. K. Murata, and Miss H. Kojima for technical assistance. This work was supported in part by the Ministry of Education, Science, Sports, and Culture of Japan through a Grant-in-Aid of Scientific Research (to M.N.). Footnotes The authors declare no conflict of interest. This article is a PNAS Direct Submission. This article contains supporting information online at www.pnas.org/cgi/content/full/0809350106/DCSupplemental. References 1. Machida YJ, Hamlin JL, Dutta A. Right place, right time, and only once: Replication. Cell. 2005;123:13–24. [PubMed] 2. Jackson DA. Nuclear organization: Uniting replication foci, chromatin domains, and chromosome structure. BioEssays. 1995;17:587–591. [PubMed] 3. Woodward AM, et al. Excess Mcm2–7 license dormant origins of replication that can be used under conditions of replicative stress. J Cell Biol. 2006;173:673–683. [PubMed] 4. Shechter D, Gautier J. ATM and ATR check in on origins: A dynamic model for origin selection and activation. Cell Cycle. 2005;4:235–238. [PubMed] 5. Shechter D, Costanzo V, Gautier J. ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol. 2004;6:648–655. [PubMed] 6. Maya-Mendoza A, Petermann E, Gillespie DA, Caldecott KW, Jackson DA. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J. 2007;26:2719–2731. [PubMed] 7. Niida H, et al. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem. 2005;280:39246–39252. [PubMed] 8. Donaldson AD, et al. CLB5-dependent activation of late replication origins in S. cerevisiae. Mol Cell. 1998;2:173–182. [PubMed] 9. Heichinger C, Penkett CJ, Bahler J, Nurse P. Genomewide characterization of fission yeast DNA replication origins. EMBO J. 2006;25:5171–5179. [PubMed] 10. Dai J, Chuang RY, Kelly TJ. DNA replication origins in the Schizosaccharomyces pombe genome. Proc Natl Acad Sci USA. 2005;102:337–342. [PubMed] 11. Patel PK, Arcangioli B, Baker SP, Bensimon A, Rhind N. DNA replication origins fire stochastically in fission yeast. Mol Biol Cell. 2006;17:308–316. [PubMed] 12. Jeon Y, et al. Temporal profile of replication of human chromosomes. Proc Natl Acad Sci USA. 2005;102:6419–6424. [PubMed] 13. Sadoni N, Cardoso MC, Stelzer EH, Leonhardt H, Zink D. Stable chromosomal units determine the spatial and temporal organization of DNA replication. J Cell Sci. 2004;117:5353–5365. [PubMed] 14. Shimada M, et al. Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell. 2008;132:221–232. [PubMed] 15. O'Keefe RT, Henderson SC, Spector DL. Dynamic organization of DNA replication in mammalian cell nuclei: Spatially and temporally defined replication of chromosome-specific α-satellite DNA sequences. J Cell Biol. 1992;116:1095–1110. [PubMed] 16. Hiratani I, Leskovar A, Gilbert DM. Differentiation-induced replication-timing changes are restricted to AT-rich/long interspersed nuclear element (LINE)-rich isochores. Proc Natl Acad Sci USA. 2004;101:16861–16866. [PubMed] 17. Aladjem MI, et al. Replication initiation patterns in the β-globin loci of totipotent and differentiated murine cells: Evidence for multiple initiation regions. Mol Cell Biol. 2002;22:442–452. [PubMed] 18. Jiang K, et al. Regulation of Chk1 includes chromatin association and 14–3-3 binding following phosphorylation on Ser-345. J Biol Chem. 2003;278:25207–25217. [PubMed] 19. Niida H, Katsuno Y, Banerjee B, Hande MP, Nakanishi M. Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol Cell Biol. 2007;27:2572–2581. [PubMed] 20. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3:421–429. [PubMed] 21. Merrick KA, et al. Distinct activation pathways confer cyclin-binding specificity on cdk1 and cdk2 in human cells. Mol Cell. 2008;32:662–672. [PubMed] 22. Th'ng JP, et al. The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell. 1990;63:313–324. [PubMed] 23. Romanowski P, et al. Interaction of Xenopus Cdc2 × cyclin A1 with the origin recognition complex. J Biol Chem. 2000;275:4239–4243. [PubMed] 24. Wuarin J, Buck V, Nurse P, Millar JB. Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication. Cell. 2002;111:419–431. [PubMed] 25. Ge XQ, Jackson DA, Blow JJ. Dormant origins licensed by excess Mcm2–7 are required for human cells to survive replicative stress. Genes Dev. 2007;21:3331–3341. [PubMed] 26. Hochegger H, et al. An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J Cell Biol. 2007;178:257–268. [PubMed] 27. Krasinska L, et al. Cdk1 and Cdk2 activity levels determine the efficiency of replication origin firing in Xenopus. EMBO J. 2008;27:758–769. [PubMed] 28. Porter AC. Preventing DNA overreplication: A Cdk perspective. Cell Div. 2008;3:3. [PubMed] 29. Fujita M, et al. Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes: A role for cdc2 kinase. J Biol Chem. 1998;273:17095–17101. [PubMed] 30. Michalet X, et al. Dynamic molecular combing: Stretching the whole human genome for high-resolution studies. Science. 1997;277:1518–1523. [PubMed] 31. Sugimura K, Takebayashi S, Taguchi H, Takeda S, Okumura K. PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA. J Cell Biol. 2008;183:1203–1212. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Cell. 2005 Oct 7; 123(1):13-24.
[Cell. 2005]Bioessays. 1995 Jul; 17(7):587-91.
[Bioessays. 1995]J Cell Biol. 2006 Jun 5; 173(5):673-83.
[J Cell Biol. 2006]Cell Cycle. 2005 Feb; 4(2):235-8.
[Cell Cycle. 2005]Nat Cell Biol. 2004 Jul; 6(7):648-55.
[Nat Cell Biol. 2004]EMBO J. 2007 Jun 6; 26(11):2719-31.
[EMBO J. 2007]J Biol Chem. 2005 Nov 25; 280(47):39246-52.
[J Biol Chem. 2005]Mol Cell. 1998 Aug; 2(2):173-82.
[Mol Cell. 1998]EMBO J. 2006 Nov 1; 25(21):5171-9.
[EMBO J. 2006]Proc Natl Acad Sci U S A. 2005 Jan 11; 102(2):337-42.
[Proc Natl Acad Sci U S A. 2005]Mol Biol Cell. 2006 Jan; 17(1):308-16.
[Mol Biol Cell. 2006]Proc Natl Acad Sci U S A. 2005 May 3; 102(18):6419-24.
[Proc Natl Acad Sci U S A. 2005]Cell. 2008 Jan 25; 132(2):221-32.
[Cell. 2008]J Cell Biol. 1992 Mar; 116(5):1095-110.
[J Cell Biol. 1992]EMBO J. 2007 Jun 6; 26(11):2719-31.
[EMBO J. 2007]EMBO J. 2007 Jun 6; 26(11):2719-31.
[EMBO J. 2007]EMBO J. 2007 Jun 6; 26(11):2719-31.
[EMBO J. 2007]Proc Natl Acad Sci U S A. 2004 Nov 30; 101(48):16861-6.
[Proc Natl Acad Sci U S A. 2004]Mol Cell Biol. 2002 Jan; 22(2):442-52.
[Mol Cell Biol. 2002]J Biol Chem. 2003 Jul 4; 278(27):25207-17.
[J Biol Chem. 2003]Mol Cell Biol. 2007 Apr; 27(7):2572-81.
[Mol Cell Biol. 2007]Cancer Cell. 2003 May; 3(5):421-9.
[Cancer Cell. 2003]Mol Cell. 2008 Dec 5; 32(5):662-72.
[Mol Cell. 2008]Cell. 1990 Oct 19; 63(2):313-24.
[Cell. 1990]J Biol Chem. 2000 Feb 11; 275(6):4239-43.
[J Biol Chem. 2000]Cell. 2002 Nov 1; 111(3):419-31.
[Cell. 2002]Genes Dev. 2007 Dec 15; 21(24):3331-41.
[Genes Dev. 2007]J Cell Biol. 2007 Jul 16; 178(2):257-68.
[J Cell Biol. 2007]EMBO J. 2008 Mar 5; 27(5):758-69.
[EMBO J. 2008]Cell Div. 2008 Jan 22; 3():3.
[Cell Div. 2008]J Biol Chem. 2000 Feb 11; 275(6):4239-43.
[J Biol Chem. 2000]Cell. 2002 Nov 1; 111(3):419-31.
[Cell. 2002]J Cell Biol. 2007 Jul 16; 178(2):257-68.
[J Cell Biol. 2007]Mol Cell. 2008 Dec 5; 32(5):662-72.
[Mol Cell. 2008]Mol Cell. 1998 Aug; 2(2):173-82.
[Mol Cell. 1998]Cell. 2008 Jan 25; 132(2):221-32.
[Cell. 2008]J Biol Chem. 1998 Jul 3; 273(27):17095-101.
[J Biol Chem. 1998]EMBO J. 2007 Jun 6; 26(11):2719-31.
[EMBO J. 2007]Science. 1997 Sep 5; 277(5331):1518-23.
[Science. 1997]J Cell Biol. 2008 Dec 29; 183(7):1203-12.
[J Cell Biol. 2008]J Biol Chem. 2005 Nov 25; 280(47):39246-52.
[J Biol Chem. 2005]Proc Natl Acad Sci U S A. 2004 Nov 30; 101(48):16861-6.
[Proc Natl Acad Sci U S A. 2004]Cell. 2008 Jan 25; 132(2):221-32.
[Cell. 2008]